Drug Development
Clinical Trial Testing
Applied DNA offers unique capabilities to analyze iCTCs in clinical trials for improved patient selection and effectiveness monitoring.
Used in patient testing in clinical trials of new cancer drugs, Applied DNA’s iCTC analysis may help patient selection and monitoring of response during therapy.